Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelubiprofen CR vs Aceclofenac in Knee Osteoarthritis
NCT02682524Phase 4Completed
- Sponsor
- Daewon Pharm
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pelubiprofen in osteoarthritis of the knee (OA) (2 arms), sponsored by Daewon Pharm. Primary endpoint: Change from baseline 100mm Pain Visual Analog Scale at 4 weeks. Started Aug 2015; status: completed.
02
Drugs
pelubiprofen
03
Conditions
osteoarthritis of the knee (OA)
Beyond the preview
Go deeper on NCT02682524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682524.